|
KR850004274A
(ko)
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
|
US4703008A
(en)
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
|
NZ210501A
(en)
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
|
AU646822B2
(en)
|
1989-10-13 |
1994-03-10 |
Kirin-Amgen Inc. |
Erythropoietin isoforms
|
|
US5856298A
(en)
|
1989-10-13 |
1999-01-05 |
Amgen Inc. |
Erythropoietin isoforms
|
|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
|
CN1057534C
(zh)
|
1993-08-17 |
2000-10-18 |
柯瑞英-艾格公司 |
促红细胞生成素类似物
|
|
US6562596B1
(en)
|
1993-10-06 |
2003-05-13 |
Amgen Inc. |
Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
|
|
US5830851A
(en)
|
1993-11-19 |
1998-11-03 |
Affymax Technologies N.V. |
Methods of administering peptides that bind to the erythropoietin receptor
|
|
US5773569A
(en)
|
1993-11-19 |
1998-06-30 |
Affymax Technologies N.V. |
Compounds and peptides that bind to the erythropoietin receptor
|
|
US5885574A
(en)
|
1994-07-26 |
1999-03-23 |
Amgen Inc. |
Antibodies which activate an erythropoietin receptor
|
|
ES2251723T3
(es)
|
1994-08-12 |
2006-05-01 |
Immunomedics, Inc. |
Inmunoconjugados y anticuerpos humanizados especificos para linfoma de celulas b y celulas de leucemia.
|
|
US5686292A
(en)
|
1995-06-02 |
1997-11-11 |
Genentech, Inc. |
Hepatocyte growth factor receptor antagonist antibodies and uses thereof
|
|
US5767078A
(en)
|
1995-06-07 |
1998-06-16 |
Johnson; Dana L. |
Agonist peptide dimers
|
|
US6753165B1
(en)
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
ATE375363T1
(de)
|
1997-07-14 |
2007-10-15 |
Bolder Biotechnology Inc |
Derivate des wachstumshormons und verwandte proteine
|
|
PT986644E
(pt)
|
1997-07-23 |
2007-01-31 |
Roche Diagnostics Gmbh |
Preparação de eritropoietina por activação genética endógena com promotores virais
|
|
US6030086A
(en)
|
1998-03-02 |
2000-02-29 |
Becton, Dickinson And Company |
Flash tube reflector with arc guide
|
|
US6310078B1
(en)
|
1998-04-20 |
2001-10-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted amino acids as erythropoietin mimetics
|
|
ATE339507T1
(de)
|
1998-06-15 |
2006-10-15 |
Gtc Biotherapeutics Inc |
Erythropoietin-analog-menschliches serum-albumin fusionsprotein
|
|
US20050181482A1
(en)
|
2004-02-12 |
2005-08-18 |
Meade Harry M. |
Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
|
|
PT1783222E
(pt)
|
1998-10-23 |
2012-07-26 |
Kirin Amgen Inc |
Péptidos diméricos de trombopoietina que simulam a ligação ao receptor mpl e têm actividade trombopoiética
|
|
PT1813624E
(pt)
|
1998-10-23 |
2010-10-27 |
Amgen Inc |
Métodos e composições para a prevenção e tratamento da anemia
|
|
DE69933044T3
(de)
|
1998-11-27 |
2016-11-24 |
Ucb Pharma, S.A. |
Zusammensetzungen und verfahren zur erhöhung der knochenmineralisierung
|
|
EP1006184A1
(en)
|
1998-12-03 |
2000-06-07 |
F. Hoffmann-La Roche Ag |
IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof
|
|
WO2000061637A1
(en)
|
1999-04-14 |
2000-10-19 |
Smithkline Beecham Corporation |
Erythropoietin receptor antibodies
|
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
AU1099601A
(en)
|
1999-10-22 |
2001-05-08 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules derived from rat brain and programmed cell death models
|
|
US20050202538A1
(en)
|
1999-11-12 |
2005-09-15 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
|
EP1228214A2
(en)
|
1999-11-12 |
2002-08-07 |
MERCK PATENT GmbH |
Erythropoietin forms with improved properties
|
|
DE60115600T2
(de)
|
2000-01-21 |
2006-07-20 |
Biovex Ltd. |
Virusstämme für die onkolytische behandlung von krebs
|
|
AUPQ599700A0
(en)
|
2000-03-03 |
2000-03-23 |
Super Internet Site System Pty Ltd |
On-line geographical directory
|
|
US6586398B1
(en)
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
|
WO2001081405A2
(en)
|
2000-04-21 |
2001-11-01 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
US6756480B2
(en)
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
|
US7078376B1
(en)
|
2000-08-11 |
2006-07-18 |
Baxter Healthcare S.A. |
Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
|
|
EE200300089A
(et)
|
2000-09-08 |
2005-02-15 |
Gryphon Therapeutics, Inc. |
Sünteetilised erütropoeesi stimuleerivad valgud, nende valmistamismeetodid ning kasutamine
|
|
US7271689B1
(en)
|
2000-11-22 |
2007-09-18 |
Fonar Corporation |
Magnet structure
|
|
DE60144439D1
(de)
|
2000-12-20 |
2011-05-26 |
Hoffmann La Roche |
Konjugate von erythropoietin (epo) mit polyethylenglykol (peg)
|
|
BRPI0116728B1
(pt)
|
2001-01-05 |
2018-10-30 |
Pfizer Inc. |
anticorpos para receptor de fator de crescimento i semelhante à insulina
|
|
DE60232870D1
(de)
|
2001-04-04 |
2009-08-20 |
Genodyssee |
Neue polynukleotide und polypeptide des erythropoietingens
|
|
ATE549354T1
(de)
|
2001-05-11 |
2012-03-15 |
Amgen Inc |
Peptide und damit zusammenhängende an tall-1 bindende moleküle
|
|
PH12012502440A1
(en)
|
2001-06-26 |
2013-06-17 |
Amgen Inc |
Antibodies to opgl
|
|
US6900292B2
(en)
|
2001-08-17 |
2005-05-31 |
Lee-Hwei K. Sun |
Fc fusion proteins of human erythropoietin with increased biological activities
|
|
IL160358A0
(en)
|
2001-08-23 |
2004-07-25 |
Genmab As |
Human antibodies specific for interleukin 15 (il-15)
|
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
WO2003055526A2
(en)
|
2001-12-21 |
2003-07-10 |
Maxygen Aps |
Erythropoietin conjugates
|
|
US7241444B2
(en)
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
|
DE60312639T2
(de)
|
2002-01-18 |
2007-11-29 |
Pierre Fabre Médicament |
Antikörper gegen igf-ir und ihre verwendungen
|
|
EP1470232A1
(en)
|
2002-01-31 |
2004-10-27 |
Oxford Biomedica (UK) Limited |
Physiologically regulated erythropoietin-expressing vector for the treatment of anaemia
|
|
GB0202252D0
(en)
|
2002-01-31 |
2002-03-20 |
Oxford Biomedica Ltd |
Anemia
|
|
ATE363541T1
(de)
|
2002-03-26 |
2007-06-15 |
Lek Tovarna Farmacevtskih |
Verfahren für die herstellung eines gewünschten profils von erythropoietin glyko-isoformen
|
|
CA2480727C
(en)
|
2002-03-29 |
2010-06-01 |
Kumiai Chemical Industry Co., Ltd. |
Gene coding for acetolactate synthase
|
|
WO2003084477A2
(en)
|
2002-03-29 |
2003-10-16 |
Centocor, Inc. |
Mammalian cdr mimetibodies, compositions, methods and uses
|
|
US20040009902A1
(en)
|
2002-05-13 |
2004-01-15 |
Irving Boime |
CTP extended erythropoietin
|
|
US7217796B2
(en)
|
2002-05-24 |
2007-05-15 |
Schering Corporation |
Neutralizing human anti-IGFR antibody
|
|
US8034904B2
(en)
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
AU2003280130B2
(en)
|
2002-06-28 |
2009-06-11 |
Centocor, Inc. |
Mammalian CH1 deleted mimetibodies, compositions, methods and uses
|
|
JP2005536992A
(ja)
|
2002-06-28 |
2005-12-08 |
セントカー・インコーポレーテツド |
哺乳動物のｅｐｏ模倣ｃｈ１欠失ミメティボディ、組成物、方法および使用
|
|
WO2004009627A1
(en)
|
2002-07-19 |
2004-01-29 |
Cangene Corporation |
Pegylated erythropoietic compounds
|
|
TW200413406A
(en)
|
2002-08-26 |
2004-08-01 |
Kirin Brewery |
Peptides and drugs containing the same
|
|
CA2824167C
(en)
|
2002-09-06 |
2018-09-25 |
Amgen Inc. |
Therapeutic human anti-il-1r1 monoclonal antibody
|
|
WO2005025606A1
(en)
|
2003-09-09 |
2005-03-24 |
Warren Pharmaceuticals, Inc. |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
|
BR0314106A
(pt)
|
2002-09-11 |
2005-07-19 |
Fresenius Kabi De Gmbh |
Polipeptìdeos hasilados, especialmente eritropoietina hasilada
|
|
US6919426B2
(en)
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
|
TWI320716B
(en)
|
2002-10-14 |
2010-02-21 |
Abbott Lab |
Erythropoietin receptor binding antibodies
|
|
US20040071694A1
(en)
|
2002-10-14 |
2004-04-15 |
Devries Peter J. |
Erythropoietin receptor binding antibodies
|
|
US7396913B2
(en)
|
2002-10-14 |
2008-07-08 |
Abbott Laboratories |
Erythropoietin receptor binding antibodies
|
|
AU2003285874A1
(en)
|
2002-10-16 |
2004-05-04 |
Amgen Inc. |
HUMAN ANTI-IFN-Gamma NEUTRALIZING ANTIBODIES AS SELECTIVE IFN-Gamma PATHWAY INHIBITORS
|
|
US6896666B2
(en)
*
|
2002-11-08 |
2005-05-24 |
Kochamba Family Trust |
Cutaneous injection delivery under suction
|
|
US20040091961A1
(en)
|
2002-11-08 |
2004-05-13 |
Evans Glen A. |
Enhanced variants of erythropoietin and methods of use
|
|
CN101287484B
(zh)
|
2002-12-20 |
2012-10-10 |
安姆根有限公司 |
抑制肌肉生长抑制素的结合剂
|
|
WO2004083248A1
(en)
|
2003-03-14 |
2004-09-30 |
Pharmacia Corporation |
Antibodies to igf-i receptor for the treatment of cancers
|
|
EP1613658B1
(en)
|
2003-04-02 |
2012-03-14 |
F. Hoffmann-La Roche AG |
Antibodies against insulin-like growth factor i receptor and uses thereof
|
|
US7220410B2
(en)
|
2003-04-18 |
2007-05-22 |
Galaxy Biotech, Llc |
Monoclonal antibodies to hepatocyte growth factor
|
|
WO2005016970A2
(en)
|
2003-05-01 |
2005-02-24 |
Imclone Systems Incorporated |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
DE602004025568D1
(de)
|
2003-05-08 |
2010-04-01 |
Novo Nordisk As |
Schwenkbare vorrichtung für eine injektionsnadel
|
|
JP4266028B2
(ja)
|
2003-05-12 |
2009-05-20 |
アフィーマックス・インコーポレイテッド |
エリスロポエチン受容体に結合する新規ペプチド
|
|
JP2007530440A
(ja)
|
2003-05-12 |
2007-11-01 |
アフィーマックス・インコーポレイテッド |
新規ポリ（エチレングリコール）修飾化合物およびその用途
|
|
SI1625156T1
(sl)
|
2003-05-12 |
2013-02-28 |
Affymax, Inc. |
Peptidi, ki se veĹľejo k eritropoetinskemu receptorju
|
|
US7074755B2
(en)
|
2003-05-17 |
2006-07-11 |
Centocor, Inc. |
Erythropoietin conjugate compounds with extended half-lives
|
|
KR20060032140A
(ko)
|
2003-05-30 |
2006-04-14 |
센토코 인코포레이티드 |
트랜스글루타미나아제를 이용한 신규 에리트로포이에틴접합체의 형성
|
|
WO2005001136A1
(en)
|
2003-06-04 |
2005-01-06 |
Irm Llc |
Methods and compositions for modulating erythropoietin expression
|
|
AR046071A1
(es)
|
2003-07-10 |
2005-11-23 |
Hoffmann La Roche |
Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
|
|
CN102408483B
(zh)
|
2003-07-15 |
2016-06-08 |
安姆根有限公司 |
作为选择性ngf途径抑制剂的人抗ngf中和抗体
|
|
KR101254371B1
(ko)
|
2003-07-18 |
2013-05-02 |
암젠 프레몬트 인코포레이티드 |
간세포 성장인자에 결합하는 분리된 항체
|
|
US20050019914A1
(en)
|
2003-07-24 |
2005-01-27 |
Aventis Pharma Deutschland Gmbh |
Perfusion process for producing erythropoietin
|
|
GB0317511D0
(en)
|
2003-07-25 |
2003-08-27 |
Biovex Ltd |
Viral vectors
|
|
US20070275871A1
(en)
|
2003-08-28 |
2007-11-29 |
Biorexis Technology, Inc. |
Epo Mimetic Peptides and Fusion Proteins
|
|
UA89481C2
(uk)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
|
|
EP1687452A4
(en)
|
2003-09-30 |
2008-08-06 |
Centocor Inc |
HUMAN HINGE-CORE MIMETICORPS, COMPOSITIONS, METHODS AND APPLICATIONS THEREOF
|
|
MXPA06004853A
(es)
|
2003-11-07 |
2006-07-06 |
Immunex Corp |
Anticuerpos que se aglutinan al receptor 4 de interleucina.
|
|
PE20050928A1
(es)
|
2003-11-21 |
2005-11-08 |
Schering Corp |
Combinaciones terapeuticas de anticuerpo anti-igfr1
|
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
|
ES2445948T3
(es)
|
2003-11-24 |
2014-03-06 |
Ratiopharm Gmbh |
Eritropoyetina glicopegilada
|
|
WO2005058967A2
(en)
|
2003-12-16 |
2005-06-30 |
Pierre Fabre Medicament |
Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof
|
|
EP1548031A1
(en)
|
2003-12-22 |
2005-06-29 |
Dubai Genetics FZ-LLC |
Nature-identical erythropoietin
|
|
WO2005065239A2
(en)
|
2003-12-31 |
2005-07-21 |
Centocor, Inc. |
Novel recombinant proteins with n-terminal free thiol
|
|
JP2008504008A
(ja)
|
2003-12-31 |
2008-02-14 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
改良された薬物動態を有するＦｃ−エリスロポエチン融合タンパク質
|
|
US7423139B2
(en)
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
|
WO2005070451A1
(en)
|
2004-01-22 |
2005-08-04 |
Zafena Aktiebolag |
Pharmaceutical composition comprising non-glycosylated erythropoietin
|
|
WO2005084711A1
(en)
|
2004-03-02 |
2005-09-15 |
Chengdu Institute Of Biological Products |
A pegylated recombinant erythropoietin that has in vivo activity
|
|
WO2005092369A2
(en)
|
2004-03-11 |
2005-10-06 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyethyl starch and erythropoietin
|
|
US20060002929A1
(en)
|
2004-03-23 |
2006-01-05 |
Khare Sanjay D |
Monoclonal antibodies
|
|
US20050227289A1
(en)
|
2004-04-09 |
2005-10-13 |
Reilly Edward B |
Antibodies to erythropoietin receptor and uses thereof
|
|
JP2008508854A
(ja)
|
2004-04-23 |
2008-03-27 |
ケンブリッジ アンティボディー テクノロジー リミテッド |
エリスロポイエチンタンパク質変異体
|
|
DE602005014117D1
(de)
|
2004-07-07 |
2009-06-04 |
Lundbeck As Valby H |
Neues carbamyliertes epo und verfahren zu dessen herstellung
|
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
|
US20060073563A1
(en)
|
2004-09-02 |
2006-04-06 |
Xencor, Inc. |
Erythropoietin derivatives with altered immunogenicity
|
|
EP1812461A2
(en)
|
2004-11-10 |
2007-08-01 |
AplaGen GmbH |
Molecules which promote hematopoiesis
|
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
|
US7906625B2
(en)
|
2005-01-24 |
2011-03-15 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
|
CA2612449A1
(en)
|
2005-06-17 |
2006-12-28 |
Imclone Systems Incorporated |
Receptor antagonists for treatment of metastatic bone cancer
|
|
WO2007000328A1
(en)
|
2005-06-27 |
2007-01-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
|
|
AU2006270009A1
(en)
|
2005-07-18 |
2007-01-25 |
Amgen Inc. |
Human anti-B7RP1 neutralizing antibodies
|
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
|
GB0603683D0
(en)
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之ｃ-ｋｉｔ抗體
|
|
MX2008014744A
(es)
|
2006-05-19 |
2009-02-10 |
Glycofi Inc |
Composiciones de eritrocpoyetina.
|
|
US7736338B2
(en)
|
2006-08-23 |
2010-06-15 |
Medtronic Minimed, Inc. |
Infusion medium delivery system, device and method with needle inserter and needle inserter device and method
|
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
|
WO2008133647A2
(en)
|
2006-11-07 |
2008-11-06 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
|
CA2667894A1
(en)
|
2006-11-07 |
2008-05-15 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
|
WO2008057458A2
(en)
|
2006-11-07 |
2008-05-15 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
|
US20100040611A1
(en)
|
2006-11-07 |
2010-02-18 |
Sparrow Carl P |
Antagonists of pcsk9
|
|
CA2671538A1
(en)
|
2006-12-14 |
2008-06-26 |
Leonard G. Presta |
Engineered anti-tslp antibody
|
|
CN101679527A
(zh)
|
2007-04-13 |
2010-03-24 |
诺瓦提斯公司 |
用于调节前蛋白转化酶枯草杆菌蛋白酶/kexin9型(pcsk9)的分子和方法
|
|
JP2010530233A
(ja)
|
2007-06-20 |
2010-09-09 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
アレルギー疾患を処置する方法および組成物
|
|
US7982016B2
(en)
|
2007-09-10 |
2011-07-19 |
Amgen Inc. |
Antigen binding proteins capable of binding thymic stromal lymphopoietin
|
|
EP2205639B1
(en)
|
2007-10-26 |
2015-12-23 |
Merck Sharp & Dohme Corp. |
Anti-pcsk9 and methods for treating lipid and cholesterol disorders
|
|
AR070316A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9)
|
|
AR070315A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
|
TWI516501B
(zh)
|
2008-09-12 |
2016-01-11 |
禮納特神經系統科學公司 |
Ｐｃｓｋ９拮抗劑類
|
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
|
US20120219558A1
(en)
|
2009-09-25 |
2012-08-30 |
Yan Ni |
Antagonists of pcsk9
|
|
WO2011053783A2
(en)
|
2009-10-30 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Ax213 and ax132 pcsk9 antagonists and variants
|
|
CN102596249A
(zh)
|
2009-10-30 |
2012-07-18 |
默沙东公司 |
Ax1和ax189 pcsk9拮抗剂和变体
|
|
AR079336A1
(es)
|
2009-12-11 |
2012-01-18 |
Irm Llc |
Antagonistas de la pro-proteina convertasa-subtilisina/quexina tipo 9 (pcsk9)
|
|
SG183867A1
(en)
|
2010-03-11 |
2012-10-30 |
Rinat Neuroscience Corp |
ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING
|
|
WO2012054438A1
(en)
|
2010-10-22 |
2012-04-26 |
Schering Corporation |
Anti-pcsk9
|
|
KR20130118925A
(ko)
|
2010-12-22 |
2013-10-30 |
제넨테크, 인크. |
항-pcsk9 항체 및 사용 방법
|
|
PL3395836T3
(pl)
|
2011-01-28 |
2021-12-13 |
Sanofi Biotechnology |
Ludzkie przeciwciała przeciwko pcsk9 do zastosowania w sposobach leczenia konkretnych grup osobników
|
|
AU2012214251A1
(en)
|
2011-02-11 |
2013-09-12 |
Novartis Ag |
PCSK9 antagonists
|
|
JOP20200043A1
(ar)
|
2011-05-10 |
2017-06-16 |
Amgen Inc |
طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
|
|
CN104619365B
(zh)
*
|
2012-09-28 |
2017-04-19 |
泰尔茂株式会社 |
穿刺装置以及药液给予装置
|
|
ES2875957T3
(es)
|
2012-12-20 |
2021-11-11 |
Amgen Inc |
Agonistas del receptor APJ y usos de los mismos
|
|
US20140274874A1
(en)
|
2013-03-14 |
2014-09-18 |
Amgen Inc. |
Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
|
|
MX380644B
(es)
|
2013-03-14 |
2025-03-12 |
Amgen Inc |
Composiciones y metodos de variantes de inhibidor tisular de la metaloproteinasa tipo tres (timp-3).
|
|
CN108704191B
(zh)
*
|
2013-05-31 |
2021-02-05 |
西兰制药公司 |
具有可插入式预填充筒的流体输送装置
|
|
US9737655B2
(en)
*
|
2013-08-23 |
2017-08-22 |
Unitract Syringe Pty Ltd |
Integrated pierceable seal fluid pathway connection and drug containers for drug delivery pumps
|
|
CN206183752U
(zh)
|
2014-04-24 |
2017-05-24 |
贝克顿·迪金森公司 |
流体输注装置
|
|
US10806855B2
(en)
*
|
2014-09-29 |
2020-10-20 |
Unl Holdings Llc |
Rigid needle insertion mechanism for a drug delivery pump
|
|
IL291672B2
(en)
*
|
2015-02-10 |
2024-02-01 |
Amgen Inc |
A rotary biased insertion mechanism for a drug delivery pump
|
|
CN107847666B
(zh)
*
|
2015-07-07 |
2020-06-02 |
伟创力有限责任公司 |
无菌贴片泵
|